Skin-Derived C-Terminal Filaggrin-2 Fragments Are -Directed Antimicrobials Targeting Bacterial Replication

1. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486: 207–14. doi: 10.1038/nature11234 22699609

2. Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer J a, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498: 367–70. doi: 10.1038/nature12171 23698366

3. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125: 183–200. 16098026

4. Harder J, Schröder J-M, Gläser R. The skin surface as antimicrobial barrier: present concepts and future outlooks. Exp Dermatol. 2013;22: 1–5. doi: 10.1111/exd.12046 23088757

5. Gallo RL, Hooper L V. Epithelial antimicrobial defence of the skin and intestine. Nature Reviews Immunology. 2012. pp. 503–516. doi: 10.1038/nri3228 22728527

6. Meyer-Hoffert U, Zimmermann A, Czapp M, Bartels J, Koblyakova Y, Gläser R, et al. Flagellin Delivery by Pseudomonas aeruginosa Rhamnolipids Induces the Antimicrobial Protein Psoriasin in Human Skin. Bozza P, editor. PLoS One. Public Library of Science; 2011;6: 11.

7. Schauber J, Gallo RL. Expanding the Roles of Antimicrobial Peptides in Skin: Alarming and Arming Keratinocytes. J Invest Dermatol. 2007;127: 510–512. 17299432

8. Fedtke I, Götz F, Peschel A. Bacterial evasion of innate host defenses—the Staphylococcus aureus lesson. Int J Med Microbiol. 2004;294: 189–94. 15493829

9. Peschel A, Vuong C, Otto M, Gotz F. The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother. 2000;44: 2845–2847. 10991869

10. Wanke I, Steffen H, Christ C, Krismer B, Götz F, Peschel A, et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol. 2011;131: 382–90. doi: 10.1038/jid.2010.328 21048787

11. Dössel J, Meyer-Hoffert U, Schröder JM, Gerstel U. Pseudomonas aeruginosa-derived rhamnolipids subvert the host innate immune response through manipulation of the human beta-defensin-2 expression. Cell Microbiol. 2012;14: 1364–1375. doi: 10.1111/j.1462-5822.2012.01801.x 22500651

12. Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, Blakesley RW, et al. A diversity profile of the human skin microbiota. Genome Res. 2008;18: 1043–50. doi: 10.1101/gr.075549.107 18502944

13. Noble WC, Hope YM, Midgley G, Moore MK, Patel S, Virani Z, et al. Toewebs as a source of Gram-negative bacilli. J Hosp Infect. 1986;8: 248–256. 2878029

14. Yu Y, Cheng AS, Wang L, Dunne WM, Bayliss SJ. Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa. J Am Acad Dermatol. 2007;57: 596–600. 17658195

15. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect (Larchmt). 2009;10: 389–397.

16. Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol. 2001;2: 1133–1137. 11694882

17. Senyürek I, Döring G, Kalbacher H, Deeg M, Peschel A, Wolz C, et al. Resistance to dermcidin-derived peptides is independent of bacterial protease activity. Int J Antimicrob Agents. 2009;34: 86–90. doi: 10.1016/j.ijantimicag.2008.12.008 19201578

18. Harder J, Bartels J, Christophers E, Schröder JM. A peptide antibiotic from human skin. Nature. 1997;387: 861. 9202117

19. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder J-M. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol. 2005;6: 57–64. 15568027

20. Harder J, Schröder J-M. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem. 2002;277: 46779–46784. 12244054

21. Harder J, Bartels J, Christophers E, Schröder J-M. Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic. J Biol Chem. 2001;276: 5707–5713. 11085990

22. Toulza E, Mattiuzzo NR, Galliano M-F, Jonca N, Dossat C, Jacob D, et al. Large-scale identification of human genes implicated in epidermal barrier function. Genome Biol. 2007;8: R107. 17562024

23. Wu Z, Hansmann B, Meyer-Hoffert U, Gläser R, Schröder J-M. Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family. PLoS One. 2009;4: e5227. doi: 10.1371/journal.pone.0005227 19384417

24. Hsu C-Y, Henry J, Raymond A-A, Méchin M-C, Pendaries V, Nassar D, et al. Deimination of human filaggrin-2 promotes its proteolysis by calpain 1. J Biol Chem. 2011;286: 23222–23233. doi: 10.1074/jbc.M110.197400 21531719

25. Pellerin L, Henry J, Hsu C-Y, Balica S, Jean-Decoster C, Méchin M-C, et al. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol. 2013;131: 1094–102. doi: 10.1016/j.jaci.2012.12.1566 23403047

26. Makino T, Mizawa M, Yamakoshi T, Takaishi M, Shimizu T. Expression of filaggrin-2 protein in the epidermis of human skin diseases: A comparative analysis with filaggrin. Biochem Biophys Res Commun. 2014;449: 100–106. doi: 10.1016/j.bbrc.2014.04.165 24813994

27. Oberhardt MA, Puchałka J, Fryer KE, Martins dos Santos VAP, Papin JA. Genome-Scale Metabolic Network Analysis of the Opportunistic Pathogen Pseudomonas aeruginosa PAO1. J Bacteriol. 2008;190: 2790–2803. doi: 10.1128/JB.01583-07 18192387

28. Zhang Z, Hou Z, Yang C, Ma C, Tao F, Xu P. Degradation of n-alkanes and polycyclic aromatic hydrocarbons in petroleum by a newly isolated Pseudomonas aeruginosa DQ8. Bioresour Technol. 2011;102: 4111–4116. doi: 10.1016/j.biortech.2010.12.064 21227683

29. Manning AJ, Kuehn MJ. Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiology. 2011. p. 258. doi: 10.1186/1471-2180-11-258 22133164

30. Sawyer JG, Martin NL, Hancock RE. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun. 1988;56: 693–698. 3125111

31. Macdonald I a, Kuehn MJ. Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa. J Bacteriol. 2013;195: 2971–81. doi: 10.1128/JB.02267-12 23625841

32. Zhang L, Dhillon P, Yan H, Farmer S, Hancock REW. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44: 3317–3321. 11083634

33. Fidai S, Farmer S, Hancock RW. Interaction of Cationic Peptides with Bacterial Membranes. In: Shafer W, editor. Antibacterial Peptide Protocols SE—13. Humana Press; 1997. pp. 187–204.

34. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y-H, Homey B, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007;449: 564–569. 17873860

35. Limoli DH, Rockel AB, Host KM, Jha A, Kopp BT, Hollis T, et al. Cationic Antimicrobial Peptides Promote Microbial Mutagenesis and Pathoadaptation in Chronic Infections. PLoS Pathog. Public Library of Science; 2014;10: e1004083. doi: 10.1371/journal.ppat.1004083 24763694

36. Schröder J-M, Harder J. Human beta-defensin-2. Int J Biochem Cell Biol. 1999;31: 645–651. 10404637

37. Chen C-R, Malik M, Snyder M, Drlica K. DNA Gyrase and Topoisomerase IV on the Bacterial Chromosome: Quinolone-induced DNA Cleavage. J Mol Biol. 1996;258: 627–637. 8636997

38. Lewin CS, Howard BMA, Smith JT. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase. J Med Microbiol. 1991;34: 19–22. 1703579

39. Clewell DB. Nature of Col E1 Plasmid Replication in Escherichia coli in the Presence of Chloramphenicol. J Bacteriol. 1972;110: 667–676. 4336693

40. Del Solar G, Giraldo R, Ruiz-Echevarría MJ, Espinosa M, Díaz-Orejas R. Replication and control of circular bacterial plasmids. Microbiol Mol Biol Rev. 1998;62: 434–64. 9618448

41. Bardan A, Nizet V, Gallo RL. Antimicrobial peptides and the skin. Expert Opin Biol Ther. Expert Opinion; 2004;4: 543–549. 15102603

42. Schröder JM, Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci. 2006;63: 469–86. 16416029

43. Rieg S, Garbe C, Sauer B, Kalbacher H, Schittek B. Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol. Blackwell Science Ltd; 2004;151: 534–539. 15377337

44. Rittié L, Sachs DL, Orringer JS, Voorhees JJ, Fisher GJ. Eccrine Sweat Glands are Major Contributors to Reepithelialization of Human Wounds. Am J Pathol. 2013;182: 163–171. doi: 10.1016/j.ajpath.2012.09.019 23159944

45. Yang L, Harroun TA, Heller WT, Weiss TM, Huang HW. Neutron off-plane scattering of aligned membranes. I. Method Of measurement. Biophys J. 1998;75: 641–645. 9675166

46. Lee M-T, Chen F-Y, Huang HW. Energetics of Pore Formation Induced by Membrane Active Peptides†. Biochemistry. American Chemical Society; 2004;43: 3590–3599. 15035629

47. Henzler Wildman KA, Lee D-K, Ramamoorthy A. Mechanism of Lipid Bilayer Disruption by the Human Antimicrobial Peptide, LL-37†. Biochemistry. American Chemical Society; 2003;42: 6545–6558. 12767238

48. Jung S, Dingley AJ, Augustin R, Anton-Erxleben F, Stanisak M, Gelhaus C, et al. Hydramacin-1, Structure and Antibacterial Activity of a Protein from the Basal Metazoan Hydra. J Biol Chem. 2009;284: 1896–1905. doi: 10.1074/jbc.M804713200 19019828

49. d’Ari R. The SOS system. Biochimie. 1985;67: 343–347. 2994755

50. Bayles KW. Bacterial programmed cell death: making sense of a paradox. Nat Rev Microbiol. 2013;12: 63–69.

51. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (“epidermal differentiation complex”) on human chromosome 1q21. J Invest Dermatol. 1996;106: 989–992. 8618063

52. Listwan P, Rothnagel JA. Keratin Bundling Proteins. In: Omary M. Bishr and PACBT-M in CB, editor. Intermediate Filament Cytoskeleton. Academic Press; 2004. pp. 817–827.

53. Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP. Loss of Normal Profilaggrin and Filaggrin in Flaky Tail (ft/ft) Mice: an Animal Model for the Filaggrin-Deficient Skin Disease Ichthyosis Vulgaris. J Investig Dermatol. The Society for Investigative Dermatology, Inc; 2000;115: 1072–1081. 11121144

54. Sandilands A, Terron-Kwiatkowski A, Hull PR, O’Regan GM, Clayton TH, Watson RM, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet. 2007;39: 650–654. 17417636

55. Mikx FH, de Jong MH. Keratinolytic activity of cutaneous and oral bacteria. Infect Immun. 1987;55: 621–625. 2434427

56. Ohnishi Y, Okino N, Ito M, Imayama S. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immunol. 1999;6: 101–104. 9874672

57. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19: 491–511. 16847082

58. Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol. 2010;64: 163–184. doi: 10.1146/annurev.micro.091208.073413 20825345

59. Maredia R, Devineni N, Lentz P, Dallo SF, Yu J, Guentzel N, et al. Vesiculation from Pseudomonas aeruginosa under SOS. ScientificWorldJournal. 2012;2012: 402919. doi: 10.1100/2012/402919 22448133

60. Keck JL, Berger JM. DNA replication at high resolution. Chem Biol. 2000;7: R63–R71. 10712935

61. Sekimizu K, Yung BY, Kornberg A. The dnaA protein of Escherichia coli. Abundance, improved purification, and membrane binding. J Biol Chem. 1988;263: 7136–7140. 2835365

62. Katayama T, Ozaki S, Keyamura K, Fujimitsu K. Regulation of the replication cycle: conserved and diverse regulatory systems for DnaA and oriC. Nat Rev Micro. Nature Publishing Group; 2010;8: 163–170.

63. Mott ML, Berger JM. DNA replication initiation: mechanisms and regulation in bacteria. Nat Rev Micro. 2007;5: 343–354.

64. Regev T, Myers N, Zarivach R, Fishov I. Association of the Chromosome Replication Initiator DnaA with the Escherichia coli Inner Membrane In Vivo: Quantity and Mode of Binding. PLoS One. Public Library of Science; 2012;7: e36441. doi: 10.1371/journal.pone.0036441 22574163

65. Skarstad K, Boye E, Steen HB. Timing of initiation of chromosome replication in individual Escherichia coli cells. EMBO J. 1986;5: 1711–1717. 3527695

66. Bolivar F, Backman K. [16] Plasmids of Escherichia coli as cloning vectors. In: Enzymology RWBT-M in, editor. Recombinant DNA. Academic Press; 1979. pp. 245–267.

67. Hansmann B, Ahrens K, Wu Z, Proksch E, Meyer-Hoffert U, Schröder J-M. Murine filaggrin-2 is involved in epithelial barrier function and down-regulated in metabolically induced skin barrier dysfunction. Exp Dermatol. 2012;21: 271–6. doi: 10.1111/j.1600-0625.2012.01449.x 22417302

68. Sambrook J, Russell DW. Molecular Cloning—Sambrook & Russel—Vol. 1, 2, 3 [Internet]. CSH Press. 2001. pp. 8.9–8.10.

69. Steinberg DA, Lehrer RI. Designer Assays for Antimicrobial Peptides. In: Shafer W, editor. Antibacterial Peptide Protocols SE—12. Humana Press; 1997. pp. 169–186. doi: 10.1385/0-89603-408-9:169

70. Ruiz-Perez F, Henderson IR, Leyton DL, Rossiter AE, Zhang Y, Nataro JP. Roles of periplasmic chaperone proteins in the biogenesis of serine protease autotransporters of Enterobacteriaceae. J Bacteriol. 2009;191: 6571–6583. doi: 10.1128/JB.00754-09 19734313

71. Hobb RI, Fields JA, Burns CM, Thompson SA. Evaluation of procedures for outer membrane isolation from Campylobacter jejuni. Microbiology. 2009;155: 979–88. doi: 10.1099/mic.0.024539-0 19246768

72. Casabona MG, Vandenbrouck Y, Attree I, Couté Y. Proteomic characterization of Pseudomonas aeruginosa PAO1 inner membrane. Proteomics. 2013;13: 2419–2423. doi: 10.1002/pmic.201200565 23744604

73. Macfarlane EL, Kwasnicka a, Hancock RE. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology. 2000;146 (Pt 1: 2543–54.